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To study the mechanisms of death following a single lethal dose of thoracic radiation, WAG/RijCmcr (Wistar)
rats were treated with 15 Gy to the whole thorax and followed until they were morbid or sacrificed for invasive
assays at 6 weeks. Lung function was assessed by breathing rate and arterial oxygen saturation. Lung structure
was evaluated histologically. Cardiac structure and function were examined by echocardiography. The
frequency and characteristics of pleural effusions were determined. Morbidity from 15 Gy radiation occurred
in all rats 5 to 8 weeks after exposure, coincident with histological pneumonitis. Increases in breathing fre-
quencies peaked at 6 weeks, when profound arterial hypoxia was also recorded. Echocardiography analysis at
6 weeks showed pulmonary hypertension and severe right ventricular enlargement with impaired left ventricu-
lar function and cardiac output. Histologic sections of the heart revealed only rare foci of lymphocytic infiltra-
tion. Total lung weight more than doubled. Pleural effusions were present in the majority of the irradiated rats
and contained elevated protein, but low lactate dehydrogenase, when compared with serum from the same
animal. Pleural effusions had a higher percentage of macrophages and large monocytes than neutrophils and
contained mast cells that are rarely present in other pathological states. Lethal irradiation to rat lungs leads to
hypoxia with infiltration of immune cells, edema and pleural effusion. These changes may contribute to
pulmonary vascular and parenchymal injury that result in secondary changes in heart structure and function.
We report that conditions resembling congestive heart failure contribute to death during radiation pneumonitis,
which indicates new targets for therapy.
Keywords: radiation pneumonitis; mast cells; right ventricular mass; tachypnea
Journal of Radiation Research, 2015, 56, 248–260
doi: 10.1093/jrr/rru095 Advance Access Publication 3 November 2014
© The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For com-
mercial re-use, please contact journals.permissions@oup.com
INTRODUCTION
The lung exhibits a steep dose-related response to ionizing
radiation [1, 2] such that there is no lethality with 12 Gy to the
thorax by 60 days but there are no survivors following pneu-
monitis with 15 Gy in WAG/RijCmcr (Wistar) rats. Radiation
typically induces two phases of injury: pneumonitis occurring
after a few weeks, and chronic fibrosis that develops months to
years later [1, 3]. In spite of decades of research the patho-
physiological mechanisms for lethal radiation-induced lung
injury at the organ level remain uncertain. Epithelial cells in
the lung [3, 4] and vascular endothelial cells [3] are injured by
radiation, while inflammatory infiltrates [4, 5] and edema [3]
appear as secondary effects in the setting of high-single or
fractionated radiation doses.
More recently, pulmonary vascular remodeling [6] and
interaction between the heart and lungs [7] have been sug-
gested as augmenting morbidity (concurrent with pneumon-
itis) 8 weeks after radiation to the whole or partial thorax of
Wistar rats. In these studies, rats were irradiated with a
single-fraction proton beam at doses of 15–20 Gy. In another
study, increments in breathing rate (a non-invasive indicator
of lung dysfunction) have been reported after radiation to the
heart alone. This occurred 10 weeks after a single X-ray dose
of 20 Gy, and 30 weeks after 15–17.5 Gy [8]. Using a single
lower dose (10 Gy) to the whole thorax, transient right ven-
tricular hypertrophy (RVH) was concurrent with the increase
in breathing rate measured during the peak of pneumonitis
[9, 10]. In the same model, increased pulmonary vascular re-
sistance, reduced arteriolar density and decreased passive
vascular distensibility that accompanied radiation pneumon-
itis were described ex vivo [9, 10]. Taken together, these find-
ings implicate abnormalities to the vasculature of the lungs
during radiation pneumonitis that then lead to right ventricu-
lar remodeling and pulmonary hypertension.
Radiation pneumonitis is associated with inflammatory
infiltrates in the lungs [5] and may arise with or without
pleural effusions [11]. While pneumonitis presents as a major
and life-threatening complication, comprehensive assess-
ments of the presence or absence of pleural effusions follow-
ing whole lung exposure in upper-half body and total body
irradiation in humans were not always reported [12–15]. From
5 to 20% of patients receiving high-dose localized radiother-
apy exhibited non-malignant pleural effusions during radi-
ation pneumonitis, a finding attributed by the authors to a
pleural reaction [1, 16, 17]. Effusions at later times may occur
in irradiated patients as a result of thoracic lymph vessel oc-
clusion by mediastinal fibrosis [18]. In mice, the timing and
volume of pleural effusions after radiation, as well as sensitiv-
ity to lung injury, varies between genetic strains [19]. The
C57L strain is highly sensitive to lethal pneumonitis but does
not develop effusions. C57BL/6 mice, on the other hand,
present with late effusions (0.1–1.8 ml/mouse) together with a
variable degree of pneumonitis [19]. In CBA mice, the pleural
effusions follow the recovery from pneumonitis, whereas
other strains, including the BALB/c strain, show earlier effu-
sions that overlap with pneumonitis [19]. An early incidence
of pleural effusions or hydrothorax has similarly been
reported in whole-thorax irradiated WAG/RijCmcr rats and
other rat strains [20, 21]. In the current study we used echocar-
diography to support evidence that lethal doses of radiation to
the whole thorax of Wistar rats cause pulmonary hypertension
and severe right ventricle (RV) enlargement. Hypoxia and
cardiac dysfunction with edema/pleural effusions were asso-
ciated with morbidity. We report that conditions that resemble
congestive heart failure contribute to death during radiation
pneumonitis, observations which position us well to investi-
gate targeted mitigation in future studies.
Materials and Methods
Animal care
All animal protocols were approved by the Institutional
Animal Care and Use Committee (IACUC). Based upon dir-
ection from the IACUC, rats were designated as morbid and
euthanized if they met specified veterinarian’s criteria. Rats
were considered morbid if they showed 20% loss in body
weight or met at least three of the following specified criteria:
(i) greater than or equal to 10% loss in body weight; (ii) in-
activity for one day, defined as no movement unless actively
stimulated; (iii) lack of grooming that became worse after
24 h; (iv) breathing rates of less than 50 or greater than 250
breaths per minute or demonstration of open-mouth breath-
ing or increased effort for breathing; (v) hunched posture on
two consecutive days.
Animals and irradiation
The studies were done in unanesthetized female WAG/
RijCmcr rats. The WAG/RijCmcr strain [22] (previously
called WAG/RijMcw, WAG/RijY and WAG/Rij) has been
used for normal tissue radiobiology studies at the Medical
College of Wisconsin (MCW) [23, 24], Yale [25, 26] and in
the Netherlands [21, 27–29] for decades. The radiation tox-
icity endpoints for bone marrow [30], skin [31], spinal cord
[29], lung [27, 32], kidney [24, 33] and heart [33, 34], have
been established in this strain. The strain is neither particular-
ly radiosensitive nor radioresistant, and the lethal dose for
whole-thorax irradiation is typical of the other rat strains that
have been studied (for a review, see Hopewell et al. [35]).
The rats were irradiated at 9–10 weeks of age, which corre-
sponded to a weight of 120–140 g [2]. The rats were placed
in a Plexiglas jig and given 15 Gy of radiation to the thorax.
An XRAD 320 orthovoltage system (Precision X-Ray, CT,
USA) was used, with a 320-kVp beam, a half-value layer of
1.4 mm Cu, and a midline dose rate of 1.43 Gy/min. The ab-
solute dose was measured with a calibrated Farmer-type ion-
ization chamber. The radiation dose was delivered by two
equally weighted parallel-opposed lateral beams to improve
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the dose uniformity. A 30 mm (right–left) × 45 mm (up–
down) collimator was used to define a radiation field that
encompassed the whole thorax. The head, kidneys and GI
tract were out of the field, while the heart and a small portion
of liver were exposed.
In batches of 10–20, rats were irradiated as above and
housed with age-matched unirradiated sibling controls. One
group of rats was sacrificed after 6 weeks for invasive end-
points. This time-point was selected for study of the irra-
diated rats because, based on our studies with this model
[2, 5, 9], all irradiated rats had developed pneumonitis. Given
the steep radiation dose–response curve, we expected no sur-
vivors by 8 weeks [2]. A second group was followed for non-
invasive endpoints until rats became morbid from radiation
pneumonitis between 5 and 8 weeks after 15 Gy. Breathing
rates (non-invasive) were taken 4, 6 and 8 weeks and pulse-
oximetry (non-invasive) was conducted 5 and 6 weeks after
irradiation in this group. Invasive assays such as lung hist-
ology, lung weights and heart weights in dissected hearts
after echocardiography were conducted at 6 weeks after
15 Gy. Pleural effusions were also collected from these rats
or those that reached the IACUC criteria for morbidity at
6 weeks after 15 Gy.
Breathing rate measurements
Breathing rates for each rat were measured every two weeks
starting 4 weeks after exposure, as described previously [10,
36]. Rats were restrained in a Plexiglas jig, which was placed
in a transparent, airtight box. A differential pressure trans-
ducer was connected to a data acquisition device (Dataq-DI
158U, Dataq Instruments Inc., Akron, OH, USA) to sense
changes in pressure in the box. The frequency of pressure
changes was recorded and analyzed. Recordings for a
maximum of 10 min per animal after two training sessions
were used. The mean breathing rate for each rat was then cal-
culated from a minimum of four steady regions of the record-
ing lasting greater than 15 s each.
Pulse oximetry
Oxygen saturation was measured in non-anesthetized rats
using a veterinary pulse oximeter (Nonin, 8600V series,
Plymouth, MN, USA) [37] connected to a computer with
WinDaq data acquisition and analysis software [10]. Rats
were acclimated to a jig placed on a warming plate (40°C)
2–3 days prior to measurements. On the day the measure-
ments were made, a probe was positioned over the tail artery
in restrained rats, and recordings from the oximeter were cap-
tured over 5–10 min. Steady traces with stable pulse readings
in the physiological range were analyzed. The mean value
for each rat was computed by an operator blinded to the treat-
ment of the rat. Average measurements were obtained from
three separate segments of recording 10–20 s in duration.
Wet/dry weight
After the rats were euthanized, the lower lobe of the right
lung was harvested, gently wiped and immediately weighed.
The same sample was dried at 60–80°C for 24 h. After
drying, the lung piece was weighed again to calculate the
ratio of wet to dry weight.
Histology of lung
Rats were anesthetized with isoflurane. After removal of the
heart and lungs from the chest, lungs were fixed, inflated
with 10% neutral buffered formalin (Fisher Scientific,
Pittsburg, PA) introduced through the airways, and then em-
bedded in paraffin [5, 10, 36]. Whole mount sections of the
left lung were cut (4 µm), processed and stained with hema-
toxylin & eosin (H&E) (Richard Allan, Kalamazoo, MI). All
histological work was performed at the Pediatric Biobank
and Analytic Tissue Core. Histological scores were obtained
from four endpoints in H&E-stained lung sections: (i) vascu-
lar wall thickness; (ii) foamy macrophages; (iii) alveolar wall
thickness; and (iv) erythrocyte score (a measure of perfu-
sion). Histologic morphometrics were performed on five ran-
domly selected fields per slide; this was done independently
in a blinded manner by the three observers (for a total of 15
sections). The scoring system was constructed so that higher
scores reflected more severe pathology. Foamy macrophages
and vascular wall thickness were analyzed as described [20].
Alveolar wall thickness was scored on a five-point scale
from five fields per rat (randomly selected over a whole
mount section of the lung): 0 = all alveoli were inflated
with lacy appearance; 1 = mild to moderate thickening in
some alveoli; 2 = thickening with signs of consolidation; 3 =
thickening with >25% consolidated areas; 4 = thickening
with >50% consolidated areas. For scoring erythrocytes,
thresholds were chosen for red-colored pixels with a hue that
was specific to erythrocytes, and that did not select eosin-
stained or other material. Identical parameters for hue, satur-
ation, brightness and background values were used for all
samples. The number of pixels obtained were divided into
four equal bins and scored as follows: 1 = highest values in
top 75% bin; 2 = 50–75%; 3 = 25–49%; 4 ≤ 25%. Scores
from all categories were summated for a total histology score
shown in Table 1.
Echocardiography
Transthoracic echocardiography was performed in anesthe-
tized (2% isoflurane) animals at 6 weeks after radiation or at
the corresponding time in unirradiated, age-matched con-
trols. Measurements and data analyses were performed by an
investigator blinded to the study groups. Animals were
studied in the left lateral decubitus position with a commer-
cially available echocardiographic system (Vivid 7, General
Electric, with an 11-MHz M12-L linear array transducer, GE
Healthcare, Waukesha, WI). Transthoracic echocardiography
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was performed from the cardiac short axis of the left ven-
tricle at the papillary muscle level, using the anatomical
M-mode feature of the Vivid 7 echo. An M-mode display
was generated from raw data 2D images with the line
selected passing through the anterior and inferior segments.
Stroke volume (SV) was measured using left ventricular end
diastolic volume (EDV) and end systolic volume (ESV)
using the formula SV = EDV – ESV. Ejection fraction (EF)
was measured using the formula EF = SV/EDV*100 [38].
Cardiac output was calculated by multiplying the heart rate ×
SV. The LV mass was derived from the anteroseptal thick-
ness (AST) and inferolateral thickness (ILT) using the
formula: 0.8 (1.04[(ILT + LVIDd + AST)3 − LVIDd3]) + 0.6
[38]. Three consecutive heart beats were measured and the
average used for analysis.
Right ventricular weight
The heart was harvested and the right ventricle was dissected
[9]. Right ventricular hypertrophy was assessed as the ratio
of the weight of the right ventricle to the weight of the left
ventricle plus septum (RV/LV + S) [9].
Histology of heart
In dedicated experiments, irradiated rats (n = 10) that
received 15 Gy to the thorax and unirradiated controls
(n = 6) were anesthetized with isoflurane at 8 weeks after ir-
radiation. The hearts were perfused with 10 ml of cardiople-
gic solution (1M KCl and 5 g/dl dextrose (D-glucose)) for
10 min. Each heart was removed, cleaned of adjoining
tissues such as the pulmonary artery and aorta and dried on a
paper towel. The atria were removed and the apex was cut,
leaving 3–4 mm of the ventricles. The right ventricle free
wall was dissected out from the left ventricle at the A–V line
and marked with ink at the base to orient the samples for
embedding in paraffin. The left ventricle was cut with the
septum and was similarly marked at the base with ink. The
tissues were fixed in 10% neutral buffered formalin for 24–
48 h prior to embedding in paraffin. Samples were sectioned
at 4 μm and stained with hematoxylin and eosin (H&E). The
sections were then examined in a blinded manner by a path-
ologist and a cardiologist. All abnormalities observed were
scored. The samples were decoded after analysis.
Collection of pleural fluid
For collections of pleural fluid, animals were anesthetized
with isoflurane; an anterior thoracotomy was performed and
all visible fluid in the pleural cavity collected. Blood was
collected from the heart by cardiac puncture. Effusions and
blood were assessed by a Clinical Laboratory Improvement
Amendments (CLIA)-approved veterinary laboratory (Marshfield
Laboratories). The inflammatory cell populations were deter-
mined by light microscopic analysis of Romanowsky-stained
cytospin preparations of the fluid. A 100-cell differential
count was performed for each effusion to determine the rela-
tive percentages of cells.
Protein assay
Total protein in the pleural fluid or serum was estimated by
the Coomassie Brilliant Blue method using a Bio-Rad Protein
Assay Kit (Cat. #500-0002, Bio-Rad, Hercules, CA, USA).
The fluids were centrifuged at 10 000g before the assay to
remove cellular debris.
Statistical analysis
All data are shown as means with standard deviations and
number of animals, except for histology scores, which are
medians with 25–75% ranges. For the multi-group compari-
sons in Figs 1–3, the significance of differences was assessed
Table 1. Summary of lung-related structure and function 42 days after 15 Gy
Parameters at 42 days
0 Gy 15 Gy
P < 0.05 0 Gy vs 15 Gy
Mean ± SD n Mean ± SD n
Body weight (gram) 167 ± 7 13 140 ± 11 30 yes
Breathing rate (breaths/minute) 135 ± 13 4 269 ± 44 8 yes
Arterial oxygen saturation (%) 92 ± 3 4 75 ± 13 8 yes
Whole lung wet weight (gram) 0.7 ± 0.1 9 1.5 ± 0.3 23 yes
Lung wet:dry weight 4.4 ± 0.1 8 4.6 ± 0.2 15 yes
Pleural effusions (milliliter) 0 ± 0 15 2.5 ± 2.5 33 yes
Histology score (sum of 4 categories) 2.8 (2.1–4.4)
Median (25–75%)
4 7.8 (6.0–9.1)
Median (25–75%)
8 yes
Right ventricular hypertrophy (RV/LV + S) 0.23 ± 0.06 4 0.44 ± 0.08 8 yes
SD = standard deviation, R = right, L = left, V = ventricle, S = septum.
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with ANOVA with the Holm-Sidak methods for dealing the
multiple comparison issues. For the two-group comparisons
in Tables 1 and 2 the significances of differences were deter-
mined by t-tests or by Mann–Whitney (the latter for hist-
ology scores).
Results
Overall health and lung-related injury after 15 Gy
Body weights in irradiated and control rats were obtained im-
mediately prior to irradiation, and at 4 and 6 weeks after ir-
radiation, as an index of overall health (Fig. 1 and Table 1).
By 6 weeks after irradiation, the weight of treated rats was
below that of their control littermates (Fig. 1 and Table 1).
Breathing rates appear in Fig. 2 and Table 1. Irradiated and
control rats have similar breathing rates at 4 weeks, but by 6
weeks following 15 Gy irradiated rats developed tachypnea.
Irradiated rats had lower values of arterial oxygen saturation
than that of controls and that of the same rats examined at 5
weeks (Fig. 3 and Table 1). Lungs from irradiated rats
doubled in wet weight and were visibly larger in size than
those of control animals (Table 1). There was a modest in-
crease in the wet:dry weight ratio of the lungs, which could
be due to a protein-rich edema as well as an increase in
cellularity (Table 1). Lung histology showed increased
Fig. 1. Radiation-induced decrease in body weight. Graph shows
body weights (mean with standard deviation) of rats in grams at
time of irradiation and 4 and 6 weeks after irradiation. Irradiated rats
(15 Gy) had lower body weight than unirradiated control rats at 6
weeks (*P < 0.05). No difference was observed for results between
the irradiation group and control at the other time-points.
n = number of rats.
Fig. 2. Radiation-induced increase in breathing rate. Breaths per
minute (Y-axis) are presented as means with standard deviations.
Irradiated rats (15 Gy) had higher breathing rate than unirradiated
(control) rats at 6 weeks (*P < 0.05). No difference was observed
for results between the irradiated group and controls at 4 weeks.
n = number of rats.
Fig. 3. Radiation-induced hypoxia. Percent oxygen (O2 saturation,
y-axis) is presented as means with standard deviations. Rats had lower
percent O2 saturation at 6 weeks after 15 Gy irradiation than
unirradiated controls (*P < 0.05 between irradiated and unirradiated,
and between irradiated at 5 vs 6 weeks). No difference was observed
for results between the irradiated group and controls at 5 weeks.
n = number of rats.
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inflammatory cells as well as alveolar and vessel wall thick-
ness, but a decrease in erythrocytes in irradiated lungs
(Fig. 4). Summated histological scores for these parameters
(see Methods and Table 1) were higher in irradiated rats than
controls. The presence and volume of pleural effusions was
variable (0–8.5 ml), occurring in 76% of irradiated rats but
not in unirradiated controls (Table 1). An increase in the
right ventricular mass was observed after 15 Gy (Table 1).
Cardiac structure and function after 15 Gy
(see Table 2 and Fig. 5)
The 2D imaging of the heart in irradiated rats showed severe
right ventricular enlargement with the interventricular
septum compressing the left ventricle and reducing the dia-
stolic or filling volume. The heart rate and stroke volume
were also reduced, consistent with compromised left ven-
tricular refilling, and cardiac outputs in irradiated rats were
decreased to ~30% that of control rats. Doppler-derived para-
meters showed that tricuspid regurgitation occurred only in
irradiated rats with markedly reduced pulmonary acceleration
time, while the ventricular relaxation times were more than
doubled. Pulmonary artery profiles reflected the develop-
ment of severe pulmonary hypertension.
No histological abnormalities were observed in H&E-
stained sections of the heart from 4/10 irradiated rats or from
any of the 6/6 hearts from unirradiated rats (Fig. 6). In 6/10
irradiated rats, we observed rare foci of chronic (lymphocytic)
inflammation in the myocardium (Fig. 6B and E), usually
constituting 10–20 lymphocytes surrounding a myocyte or
blood vessel. These foci of inflammation were not reprodu-
cibly localized to a single ventricle or an area of the ventricu-
lar wall. In one animal, this inflammation was associated
with a single focus of myocyte damage (Fig. 6C and F). The
heart of one irradiated animal contained hemosiderin-laden
macrophages surrounding small blood vessels in the myocar-
dium (consistent with prior injury), but no other inflamma-
tion. Outside of these foci, there was no evidence of
myocardial or vascular injury or fibrosis.
Analysis of pleural effusions (see Table 3)
Gross pleural effusions were recorded in 60% of rats (n = 6/
10) that met IACUC criteria for euthanasia between 5 and
8 weeks after 15 Gy. In studies terminated at 6 weeks, 76%
of rats (from n = 33) had pleural effusions. Lung weights in
rats without pleural effusions were higher than those of rats
with effusions (1.8 ± 0.2 g, n = 6 vs 1.4 ± 0.3 g, n = 9;
Table 2. Summary of cardiac structure and function at 42 days after 15 Gy
Echocardiogram at 42 days Abbreviation definition
Mean ± SD
(n = 5–6 rats/group) P < 0.05 0 Gy vs15 Gy
0 Gy 15 Gy
RV width (cm) right ventricular width 0.23 ± 0.06 0.44 ± 0.06 yes
RV free wall (cm) right ventricular free wall 0.09 ± 0.02 0.14 ± 0.05 yes
LVIDd (cm) left ventricular internal dimension (diastole) 0.60 ± 0.05 0.44 ± 0.11 yes
EDV (T) (ml) end-diastolic volume 0.51 ± 0.11 0.23 ± 0.14 yes
SV (ml) stroke volume 0.44 ± 0.12 0.17 ± 0.09 yes
HR (beats/min) heart rate 421 ± 37 307 ± 46 yes
CO (ml/min) cardiac output 187 ± 55 55 ± 31 yes
TR tricuspid regurgitation (leaking tricuspid valve) unmeasurable moderate
Max velocity (m/s) maximum velocity unmeasurable 3.03 ± 0.39
Pressure gradient (mm Hg) pressure gradient unmeasurable 38.0 ± 10.1
TPVR (ms−1m) total pulmonary vascular resistance unmeasurable 214 ± 35
MPA end-diastolic pressure
(mm Hg)
main pulmonary artery end-diastolic pressure unmeasurable 6.8 ± 1.7
RVOT VTI (cm) right ventricular outflow tract unmeasurable 1.5 ± 0.4
PASP (mm Hg) pulmonary artery systolic pressure unmeasurable 74 ± 8
PAT (ms) pulmonary acceleration time 30.7 ± 8.6 13.0 ± 2.1 yes
PAT/ET Indicator for pulmonary hypertension 42.2 ± 6.6 19.0 ± 4.2 yes
IVRT (ms) isovolumetric relaxation time 14.6 ± 2.5 39.6 ± 7.6 yes
e’ (m/s) early diastolic mitral annulus velocity 0.08 ± 0.2 0.03 ± 0.1 yes
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P = 0.008). Values for parameters used to define transudative
versus exudative effusions in humans by Light’s and related
criteria are shown in Table 3A. Table 3B describes the total
and differential cell count from seven randomly selected effu-
sions, indicating the presence of mostly inflammatory cells
such as macrophages. Mast cells were present in the majority
of samples. Based on these results, most effusions were
described as modified transudates to reflect shared character-
istics of both transudation and exudation.
DISCUSSION
To study the pathophysiological sequences leading to death
after thoracic irradiation in the rat we administered 15 Gy to
the whole thorax, which was previously shown to cause
100% lethality from pneumonitis [2]. Our goal was to
examine the role of the heart and radiation-associated pleural
effusions in this morbidity. This model provides several new
insights. First, we are unaware of other studies that have
quantified oxygenation status in rats after thoracic radiation.
Second, concurrent with profound hypoxia, we observed
severe pulmonary hypertension with right ventricular en-
largement and echocardiographic signs of pressure and
volume overload, and associated left ventricular dysfunction
such that cardiac output was decreased to ~30% of that in
control rats. In the context of increased pulmonary vascular
resistance, which we have previously reported for whole-
thorax irradiation [9, 39], these data suggest the occurrence
of hypoxic pulmonary pathophysiology with secondary
cardiac remodeling and decreased cardiac output [40] follow-
ing a radiation dose to the thorax that is considered subthres-
hold for direct cardiac damage (Fig. 7). Minimal to no
histological cardiac pathology was observed in our rats
following irradiation, and the rare foci of mild lymphocytic
inflammation would not account for the cardiac dysfunction
or explain the pleural effusions observed in irradiated rats.
Third, although pleural effusions are a well-recognized con-
sequence of thoracic radiation in rodents, our study indicated
that these effusions can be quantified and characterized bio-
chemically and cytologically. We conclude that radiation-
induced pleural effusions in the rats appear to be attributable
to both hydrostatic (low left ventricular output) and inflam-
matory mechanisms; they are associated with a cellular com-
ponent that includes a variety of leukocytes, and have
biochemical values consistent with both exudative and trans-
udative processes. The extent to which our findings extend to
male (or elderly) rodents or to other strains remains to be
determined.
Our long-term goal is to develop mitigators for radiation
injuries to the lung induced by a single dose of ionizing radi-
ation at doses relevant to a radiological attack or nuclear ac-
cident. The National Institutes of Health (USA) has initiated
a radiation countermeasures development program that
requires such mitigators to be approved under the Federal
Drug Administration (USA) ‘animal rule’, since relevant
high single-doses of radiation cannot be ethically delivered
to humans [41]. For this reason, animal models that repro-
duce radiation injuries in humans are required. Rodents are
the animal models of choice, because they are well charac-
terized, easy to work with, and have genetically altered
strains available for advanced research [41, 42]. Thus the
pathophysiology of radiation injury needs to be determined
in animal models to successfully navigate the FDA animal
rule.
Fig. 4. Radiation-induced changes in representative H&E-stained
lung sections (4 μm thick) pointing out four categories scored in
Table 1: (A) lung from unirradiated rat; (B) lung from irradiated (15
Gy) rat; (C) magnified image of boxed area in A. (D) magnified
image of boxed area in B. Solid and dashed arrows in (A) point to
blood vessels and alveolar walls respectively, which appear thicker
in the irradiated lung (B). Green arrows in the irradiated lung
section (B) point to abundant foamy macrophages. Red arrows
point to red blood cells. Note the well perfused alveolar capillaries
in unirradiated lungs (C) as compared with the poorly perfused
capillaries in irradiated lungs (D).
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Fig. 5. Echocardiographic evidence of pulmonary artery hypertension in irradiated rats. Columns represent control rats
(left-side) or irradiated rats (right-side) and rows represents four different imaging windows: (1) parasternal short-axis, (2)
apical four-chamber views using B-mode at end-diastole to demonstrate right ventricular remodeling, (3) high parasternal
short-axis view with pulsed-wave Doppler is used to detect pulmonary artery flow, and (4) apical four-chamber view with color
Doppler is used to detect tricuspid regurgitation (red arrows). The parasternal short axis and apical four-chamber views show
right ventricular dilatation with concomitant decrease in left ventricle. The pulmonary artery profiles reflect the presence of
pulmonary hypertension. Normal, round-shaped flow profile is found in the control hearts, whereas a blunted flow profile with
a sharp peak at early systole and a decreased acceleration time and increased deceleration is seen in the irradiated rat heart.
There is no detectable tricuspid regurgitation by color Doppler in control rats, but tricuspid regurgitation is common in the
irradiated group. R = right, L = left, A = atrium, V = ventricle.
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Our previous studies, and those of others [3, 6, 9], indicate
that injury to the pulmonary vascular endothelium and vessel
wall reduce vascular reactivity after 10 Gy to the thorax [10].
Blood vessels are also less distensible than in unirradiated
rats [9], and increased pulmonary vascular resistance was
measured in lungs ex vivo. Vascular dropout was seen by
angiography [9]. Vascular injury and dropout along with in-
flammatory infiltrates could hinder the ability of the lung to
match perfusion with ventilation, consistent with hypoxemia.
We have observed compensatory RVH after a non-lethal
dose of irradiation (10 Gy) [9]. Higher doses of irradiation in
a different strain of Wistar rats induced perivascular and pul-
monary edema with increased pulmonary artery pressure and
left ventricular relaxation times, indicative of biventricular
diastolic dysfunction [6, 7]. The authors of the latter study
concluded that irradiation of the heart and lung enhanced the
severity of radiation pneumonitis [6, 7] although description
of pleural effusions was minimal as compared to earlier
studies in rats [20, 21]. Interactions between the irradiated
heart and lungs have also been reported after localized
irradiation of the heart [6, 8]. In the present study, we
observed hypoxia, pulmonary hypertension, reduction in left
ventricular diameter at diastole and decreased cardiac output
at 6 weeks following a lethal whole-thorax dose. These data
do not exclude direct effects of radiation on the heart, but
provide sufficient pathophysiology to explain morbidity
based primarily on pulmonary responses to radiation (Figs 3
and 7).
The pathophysiological link between cardiac remodeling
and radiation-induced changes to the lung is strengthened by
three observations. First, with lower doses of thoracic radi-
ation (10 Gy) that allow rats to survive pneumonitis, spontan-
eous recovery from lung pathology is associated with
reversal of RVH [9]. With lower radiation doses that pro-
duced limited pneumonitis (5 Gy), no RVH was identified at
times corresponding to pneumonitis. Second, thoracic radi-
ation inducing pneumonitis is accompanied by pulmonary
vascular dropout, decreased pulmonary vascular distensibil-
ity and increased vascular resistance, changes that induce
right heart remodeling. Third, mitigation of lung injury after
Fig. 6. Histological findings in irradiated rat hearts. H&E stains of hearts taken at two magnifications from unirradiated (A and
D) and irradiated (B, C, E and F) rats reveal scattered foci of lymphocytic inflammation in a subpopulation of irradiated rats. One
irradiated rat showed cardiac myocyte necrosis (C and F, arrows) associated with lymphocytic inflammation. Bars = 80 μm (A, B
and C) and 40 μm (D, E and F).
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thoracic radiation by angiotensin-converting enzyme (ACE)
inhibitors yields decreased pneumonitis, decreased pulmon-
ary vascular dropout, increased pulmonary vascular distensi-
bility, decreased pulmonary vascular resistance and improved
survival [2, 39, 43]. The pathophysiological consequences of
radiation-induced pleural effusion remain to be fully resolved.
Effusions were not reported as present or absent in early
studies of whole-lung irradiation in humans [13–16].
Clinically, patients with heart failure can develop pleural effu-
sions resulting from increased interstitial fluid in the lung
caused by elevated hydrostatic pressure [40]. Typically this
occurs in patients with left-sided heart failure, but it has also
been seen occasionally in patients with right-sided heart
failure. Fluid moves from the pulmonary interstitial space
across the visceral pleura into the pleural space along a pres-
sure gradient. In this case, the fluid is typically a transudate,
though 25% of cases may fall into the exudative category.
Radiation injury to the lymphatics may also be a contributing
factor to impaired drainage of the pleural space [18].
In rodents, congestive heart failure is reported to lead to a
‘protein rich transudate’ [44]. Effusions are caused primarily
by increased alveolar capillary pressures, and decreased
cardiac output [44], the latter of which we observed. Venous
congestion leads to increased pressure in the posterior vena
cava, reducing lymphatic drainage from the pleural cavity.
Such transudates have a relatively high protein content
because the vessels become permeable to plasma proteins
[44]. Exudates form when there is increased vascular perme-
ability caused by inflammatory cells accompanied by migra-
tion of (mostly) neutrophils [44]. Frequently a mixture of
macrophages and lymphocytes accompany the neutrophils.
High-volume pleural effusions (up to 10 ml) have been noted
Table 3: Summary of pleural effusion in irradiated (15 Gy) rats after 42 days
A. Pleural fluid # Transudate # Exudate
Appearance
Criteria Clear Cloudy
15 Gy rats 0/9 9/9 (mean 2.4 ± 0.7)
Specific gravity
Criteria ≤1.012 ≥1.020
15 Gy rats 0/9 9/9 (mean 1.023 ± 0.003)
Fluid:serum protein
Light’s criteria <0.5 >0.5
15 Gy rats 1/7 (0.19) 6/7 (mean 0.73 ± 0.2)
Fluid:serum LDH
Light’s criteria <0.6 >0.6
15 Gy rats 7/7 (mean 0.4 ± 0.1) 0/7
Cholesterol (mg/dl)
Criteria <45 >45
15 Gy rats 8/9 (mean 32 ± 8) 1/9 (48)
B. Differential cell count for individual rats
# white blood cells (wbc)/μl
%Macrophages/large
monocytes
%monocytes % lymphocytes % neutrophils % mast cells
1060 35 – 59 4 –
2870 87 – 4 6 3
1530 85 – 6 7 2
176 80 – 3 8 1
2900 87 – 3 3 7
492 93 – – 1 rare
290 95 3 – 2 –
A = criteria for classifying human effusions (values for human effusions are included in bold font). B = differential cell count.
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in Wistar rats following whole-thorax irradiation [20, 21].
Because thoracic volumes are constrained by boney struc-
tures, large pleural effusions restrict lung parenchymal
volume. When interstitial or alveolar fluid moves into the
pleural space, it is reasonable to expect that lungs of rats with
pleural effusion would weigh less than those with pulmonary
edema but no pleural effusion, as we observed.
In the current study, pleural effusions were classified as
modified transudates by a CLIA-approved veterinary labora-
tory. The samples qualified as exudates based on the criteria
for human effusions (e.g. protein content and cholesterol
ratios), but were transudative based on lactate dehydrogenase
(LDH). In addition, the predominant cellular constituents
were macrophages and large monocytes, as compared with
neutrophils. One of the most striking characteristics of effu-
sions in this study is the presence of mast cells (Table 3B).
These cells are increased in irradiated rat lungs [5, 45]. Mast
and other infiltrating cells release inflammatory mediators
and cytokines in irradiated lungs that can alter vascular per-
meability and promote pulmonary hypertension. Thus, we
postulate that pleural effusions occurring in rats after lethal
doses of radiation may be due to a combination of multiple
factors. These would include hypoxia-induced increase in
pulmonary vascular resistance, right ventricular remodeling
and impaired left ventricular function with transudative
effusions, conditions that would result in congestive heart
failure. Also, an increase in vascular permeability via inflam-
matory mediators secreted by infiltrating immune cells in
irradiated lungs would promote exudative types of effusion.
Radiation injury to the draining lymphatic system could also
lead to exudative pleural effusions.
Pleural effusions are common in mice after whole-thorax
irradiation, but not always coincidental with pneumonitis
[19]; the status of the hearts in these mice has not been
reported [11, 19]. Effusions in CBA mice arise independently
after the resolution of pneumonitis, and fall in an exudative
category [19]. Interestingly, some mouse strains, (e.g. BALB/c)
show early pleural effusions with pneumonitis, as observed
in our rats. This mouse strain also exhibits a strong mast cell
infiltration in the lung, but the connection to pulmonary
hypertension and cardiac injury remains to be explored [45].
Effusions were observed after whole-thoracic irradiation of
non-human primates, with a frequency as high as 75% at 12
Gy [46]. It was common to encounter radiation-associated
pleural effusions in humans undergoing radiotherapy [1];
but improvements in dose-delivery and treatment planning
have largely prevented lethal pneumonitis, and so pleural
effusions may now be less frequent in this population.
Dexamethasone eliminated lethal pleural fluid accumulation
in rats (and possibly in primates) after partial-body irradi-
ation [46, 47]; thus the standard clinical use of steroids and
diuretics to treat radiation pneumonitis and effusions may
also account for the low reported incidence of pleural
effusions in patients receiving radiotherapy.
One of the first, and most successful to date, class of
countermeasures described for lung injury, ACE inhibitors,
also reduce blood pressure and improve pathological vascu-
lar remodeling [48]. Since we present evidence that vascular
injury and pulmonary artery hypertension play a role in radi-
ation pneumonitis, ACE inhibitors may be expected to miti-
gate lung injury as well as improve survival after radiation.
In fact, these drugs have improved pulmonary-related out-
comes after radiotherapy in the clinic [49, 50]. In summary, a
better understanding of the sequence of pathophysiological
events of radiation pneumonitis will enable therapeutic
intervention after radiological events or radiotherapy.
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